ArticleBMC bioinformatics2024
C-ziptf: stable tensor factorization for zero-inflated multi-dimensional genomics data.
Article in BMC bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors.Nature communications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the past two decades, genomics has advanced significantly, with single-cell RNA-sequencing (scRNA-seq) marking a pivotal milestone. ScRNA-seq provides unparalleled insights into cellular diversity and has spurred diverse studies across multiple conditions and samples, resulting in an influx of complex multidimensional genomics data. This highlights the need for robust methodologies capable of handling the complexity and multidimensionality of such genomics data. Furthermore, single-cell data grapples with sparsity due to issues like low capture efficiency and dropout effects. Tensor factorizations (TF) have emerged as powerful tools to unravel the complex patterns from multi-dimensional genomics data. Classic TF methods, based on maximum likelihood estimation, struggle with zero-inflated count data, while the inherent stochasticity in TFs further complicates result interpretation and reproducibility. Our paper introduces Zero Inflated Poisson Tensor Factorization (ZIPTF), a novel method for high-dimensional zero-inflated count data factorization. We also present Consensus-ZIPTF (C-ZIPTF), merging ZIPTF with a consensus-based approach to address stochasticity. We evaluate our proposed methods on synthetic zero-inflated count data, simulated scRNA-seq data, and real multi-sample multi-condition scRNA-seq datasets. ZIPTF consistently outperforms baseline matrix and tensor factorization methods, displaying enhanced reconstruction accuracy for zero-inflated data. When dealing with high probabilities of excess zeros, ZIPTF achieves up to
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.